Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06862557 · ClinicalTrials.gov registry record · NA
Pulsed Electromagnetic Field Treatment With Dementia Patients
A NA study of Alzheimers Disease and Vascular Dementia, sponsored by Herrick Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06862557: Recruiting NA study of Alzheimers Disease and Vascular Dementia, sponsored by Herrick Medical.
NCT06862557 is a NA study of Alzheimers Disease and Vascular Dementia that is actively recruiting participants, run by Herrick Medical. The registered enrollment target is 48 participants, below the 3,926-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06862557, a NA study of Alzheimers Disease and Vascular Dementia, is actively recruiting participants, sponsored by Herrick Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
An open label pilot study in mild to moderate AD/ADRD patients to assess the effects of treatment with ECHS AD/ADRD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end point is the The Alzheimer's Disease Assessment Scale-Cognitive Subscale. Participants will be followed-up for 9 months post-treatment.
Primary Outcome
Assessment consisting of 11 tasks, taking up to 30mins, to measure the severity of cognitive dementia symptoms. Score 0-70, Higher number, more severity.
Conditions Studied
Interventions
- DEVICE ECHS AD Device
Study Locations (1)
Florida
- University of Miami - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT06862557 shows while recruiting
NCT06862557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 3,926-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Alzheimers Disease appearing as the primary indexed condition, and to 1 intervention - of which ECHS AD Device is the first listed.
NCT06862557 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06862557 about?
NCT06862557 is a clinical study titled "Pulsed Electromagnetic Field Treatment With Dementia Patients". An open label pilot study in mild to moderate AD/ADRD patients to assess the effects of treatment with ECHS AD/ADRD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over ...
What is the current status of trial NCT06862557?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-04-01. Estimated completion is 2026-09-30.
What conditions does trial NCT06862557 study?
This clinical trial studies the following conditions: Alzheimers Disease, Vascular Dementia, Lewy Body Dementia.
What interventions are being tested in trial NCT06862557?
The interventions under investigation include: ECHS AD Device (DEVICE).
Who is sponsoring clinical trial NCT06862557?
This trial is sponsored by Herrick Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06862557 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06862557's enrollment target sits among peer trials
48 99th of 147 higher than 48 of 147 other Alzheimers Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimers Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
University of Central Florida Music Study
RECRUITING · NA
-
Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
RECRUITING · NA
-
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
RECRUITING · NA
-
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
RECRUITING · NA
-
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
RECRUITING · NA
-
Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI